MEDINDIA
English
हिन्दी
Español
français
中文
In South Africa a new sub-variant of COVID-19 Omicron called BA.2.75 has been detected. With South Africa having lifted all major COVID-19 lockdown restrictions.
Omicron Variant of COVID-19
Omicron variant is a mutated strain of coronavirus (SARS-CoV-2) with faster transmissibility and enhanced virulence compared to the original COVID-19 virus.
Omicron variant is a mutated strain of coronavirus (SARS-CoV-2) with faster transmissibility and enhanced virulence compared to the original COVID-19 virus.
TOP INSIGHT
Mohale encouraged those who remained unvaccinated to get the vaccines and receive booster shots to protect themselves. More than 50 percent of the population in South Africa has been vaccinated.
New Sub-Variant of Omicron Variant
The Spokesperson told Xinhua that BA.4 and BA.5 continued to be the most dominant sub-variants in South Africa but they were less severe due to higher levels of immunity. The department called on the people not to panic.With South Africa having lifted all major COVID-19 lockdown restrictions as new cases continued declining, the Health department, however, said the pandemic was not over.
Source-IANS
Next COVID Threat: BA.5 Omicron Subvariant is Now Dominant in the US
Watch out: BA.5 Omicron subvariant, now the dominant coronavirus strain in the US, made up almost 80 per cent of new COVID-19 infections in the country.
Watch out: BA.5 Omicron subvariant, now the dominant coronavirus strain in the US, made up almost 80 per cent of new COVID-19 infections in the country.
Most People Infected with Omicron Didn�t Know it, Says Study
More than one in every two people who were infected with Omicron didn’t know they had it, revealed study.
More than one in every two people who were infected with Omicron didn’t know they had it, revealed study.
New Vaccine to Treat COVID-19 and Its Variant Omicron
The UK has become the first country to develop and approve a new COVID-19 jab specifically targeting the variant Omicron by the company Moderna.
The UK has become the first country to develop and approve a new COVID-19 jab specifically targeting the variant Omicron by the company Moderna.
Email
